scholarly journals The relation between the severity of breast cancer-related lymphedema and quality-of-life

2016 ◽  
Vol 27 ◽  
pp. vi517
Author(s):  
M.A. Abou-Elenein ◽  
W.S. Makar ◽  
H.M. Abdel-Azim ◽  
S.A. Alsirafy
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Breast Cancer Related Lymphedema

Breast cancer-related lymphedema and quality of life: A qualitative analysis over years of survivorship

2019 ◽  
pp. 174239531987279
Author(s):  
Allison B Anbari ◽  
Ausanee Wanchai ◽  
Jane M Armer
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Healthcare Providers ◽  
Breast Cancer Diagnosis ◽  
Data Saturation ◽  
Breast Cancer Related Lymphedema ◽  
Reported Data ◽  
The Impact

Objectives The study purpose was to examine perspectives of women with newly diagnosed breast cancer-related lymphedema (BCRL) regarding their quality of life over seven years. Method Data were collected over seven years using the Lymphedema and Breast Cancer Questionnaire (LBCQ). Participants with BCRL answered open-ended questions corresponding to changes in mood and lifestyle from post-op through annual interviews and surveys. Self-reported data from 97 participants with BCRL were analyzed using in vivo coding and template-style content analysis to elicit the impact of BCRL on quality of life domains. Results Data saturation was achieved as participants neared 30 to 36 months post- breast cancer diagnosis. Three major themes were identified related to BCRL’s impact on: physical function; daily living and social function; and psychological function. Discussion Findings suggest that BCRL impacts quality of life not only soon after diagnosis, but also throughout survivorship years. Healthcare providers should develop programs to enhance quality of life for survivors with BCRL.

Optimizing Quality of Life for Patients with Breast Cancer–Related Lymphedema

2020 ◽  
Vol 145 (4) ◽  
pp. 676e-685e ◽  
Author(s):  
Edward I. Chang ◽  
Amir Ibrahim ◽  
Jun Liu ◽  
Charee Robe ◽  
Hiroo Suami ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Breast Cancer Related Lymphedema

scholarly journals The effects of complex decongestive therapy on kinesthetic sense of hands, upper extremity function, and quality of life in patients with breast cancer-related lymphedema

2021 ◽  
Vol 67 (2) ◽  
pp. 211-217
Author(s):  
Hilal Yeşil ◽  
Sibel Eyigör ◽  
Menekşe İnbat ◽  
Ferah Bulut
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Upper Extremity ◽  
Kinesthetic Sense ◽  
Extremity Function ◽  
Eortc Qlq C30 ◽  
Upper Extremity Function ◽  
Breast Cancer Related Lymphedema ◽  
Eortc Qlq

Objectives: This study aims to investigate the effect of complex decongestive therapy (CDT) on the kinesthetic sense of hands, upper extremity function, and the quality of life in patients with breast cancer-related lymphedema (BCRL). Patients and methods: Between August 2018 and August 2019, total of 50 women with BCRL (mean age: 56.5±9.6 years; range, 36 to 71 years) were included in the study. Kinesthetic sense of the hand, upper extremity function (Disabilities of the Arm, Shoulder and Hand [DASH]), quality of life (European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire [EORTC QLQ-C30]), and arm volume of all patients were evaluated before and after the treatment. All patients received CDT for 20 sessions for 1 h over a total of four weeks. Results: A statistically significant decrease in the volume of the involved extremity was observed after the treatment (p<0.001). There was a significant decrease in the symptom score (p<0.001) and a significant improvement in the general health status and functional scales of the EORTC QLQ-C30 (p<0.001 and p=0.012, respectively). The DASH scores and visual and kinesthetic sense scores of the patients significantly improved after the treatment (p=0.016, p=0.008, and p<0.001, respectively). Conclusion: Our study results show that BCRL is a serious complication which may lead to impairment in the kinesthetic sense of hand and upper extremity function with the increased arm volume. The CDT is an effective and safe method not only to achieve significant volume reduction in the extremities, but also to achieve favorable results in managing these problems.

scholarly journals EFFECTIVENESS OF MANUAL LYMPHATIC DRAINAGE IN IMPROVING QUALITY OF LIFE AMONG WOMEN WITH BREAST CANCER RELATED LYMPHEDEMA

2018 ◽  
Vol 7 (2) ◽  
pp. 38-44
Author(s):  
Nazia Iqbal ◽  
Hussaini Begum ◽  
Amanullah Khan
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Lymphatic Drainage ◽  
The Body ◽  
Care Hospital ◽  
Manual Lymphatic Drainage ◽  
Impact Scale ◽  
Life Impact ◽  
Breast Cancer Related Lymphedema

BACKGROUND & AIM The body of evidence related to higher incidence of breast cancer related lymphedema after breast surgeries concluded compromise Quality of Life (QoL) among women over the past decade. The aim of this study is to evaluate the effectiveness of Manual Lymphatic Drainage (MLD) in improving QoL among women with Breast cancer related Lymphedema. STUDY DESIGN & PARTICIPANTS A Quasi Experimental study was conducted on women of the age 36-60 years with stage I and II breast cancer related lymphedema at Rehabilitation Department of a tertiary care Hospital. METHODS Total 70 women recruited with lymphedema were assessed at baseline and after treatment on Lymphedema Life Impact Scale. Manual lymphatic drainage technique was applied for 3 days in a week for 6 weeks with a compression bandage for first 4 weeks. RESULTS The findings showed that Manual Lymphatic Drainage (MLD) technique significantly improves the Lymphedema Life Impact Scale score after intervention p <0.05 notably in psychological domain of the scale p=0.0001 furthermore, the percentage of impairment was also reduced significantly from 75.98% to 44.18%.

scholarly journals Quality of Life for Women with Breast Cancer-Related Lymphedema: The Importance of Collaboration between Physical Medicine and Rehabilitation and General Surgery Clinics

2021 ◽  
pp. 119-126
Author(s):  
Türkan Turgay ◽  
Pınar Günel Karadeniz ◽  
Göktürk Maralcan
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Body Image ◽  
Axillary Dissection ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
Physical Medicine ◽  
Significant Difference ◽  
Breast Cancer Related Lymphedema

Background: The aim of this study was to examine the clinical characteristics and quality of life (QOL) of patients with BCRL (breast cancer-related lymphedema).Methods: In this cross-sectional descriptive study, patients' characteristics such as age, body mass index (BMI: kg/m²), history of chemotherapy (CT), radiotherapy (RT), hormone replacement therapy (HRT), neoadjuvant therapy (NT), cancer stages, and types of surgery were recorded. Patients were evaluated using the ‘Disabilities of the Arm, Shoulder and Hand questionnaire’ (DASH), the ‘Lymphedema Quality of Life Questionnaire’ (LYMQOL-ARM), and a visual analogue scale (VAS). Results: A total of 68 women with the mean age of 52.50±9.33 and BMI 29.240 ± 5.05 kg/m² were recruited after breast cancer surgery in this study: thirty-three patients (48.5%) in Stage 0; 24 (35.3%) in Stage 1; 10 (14.7%) in Stage 2; and 1 (1.5%) in Stage 3. No statistically significant difference was found in the QOL according to treatments received after the diagnosis of breast cancer surgery, RT (except the appearance domain of QOL), CT, HRT, or NT. In patients who had received axillary dissection in combination with RT, a statistically significant association was observed between QOL related to body image and symptoms (p=0.009 and p=0.017, respectively). A statistically significant difference was found only in body image and clinical symptom domains according to the lymphedema stage (p=0.027 and p=0.002, respectively). It was observed that as shoulder pain (VAS) and disability (DASH) scores increased, scores of all domains of QOL increased except the overall domain in QOL (p<0.05). Conclusion: It was observed that clinical symptoms and body image parameters in QOL were associated with the lymphedema stage and the number of lymph nodes dissected. It was concluded that axillary dissection with axillary RT and RT alone after breast cancer surgery is associated with body image. Our study revealed that body image perception is related to the quality of life in patients with BCRL. Optimal management of the negative effects of self-reported lymphedema evaluated in the latency phase on quality of life requires coordination between Physical Medicine and Rehabilitation and General Surgery Clinics.

scholarly journals Combined-complex Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients with Breast Cancer-related Lymphedema

2020 ◽  
Author(s):  
Pinar Borman ◽  
Aysegul Yaman ◽  
Sina Yasrebi ◽  
Adeviye Pinar Inanli
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Functional Status ◽  
Excess Volumes ◽  
Complex Decongestive Therapy ◽  
Eortc Qlq C30 ◽  
Breast Cancer Related Lymphedema ◽  
Eortc Qlq ◽  
Decongestive Therapy

Abstract Background: The aim of this study was to evaluate the effects of complex decongestive therapy (CDT) in patients with breast cancer-related lymphedema (BCRL), in regard to volume reduction, functional status and quality of life (QoL).Methods: Fifty patients with unilateral BCRL were included. The demographic variables focusing on lymphedema were recorded. All patients received combined phase 1 CDT including skin care, manual lymphatic drainage, multilayer bandaging and supervised exercises, five times a week for three weeks, as a total of 15 sessions. Patients were assessed by limb volumes and excess volumes according to geometric approximation derived from serial circumference-measurements of the limb, prior and at the end of third week. The functional disability was evaluated by quick disability of arm, shoulder and hand questionnaire (DASH). Quality of life was assessed by the European Organization forResearch and Treatment of Cancer Core Cancer Quality of Life Questionnaire (EORTC-QLQ-C30) and its breast cancer module (EORTC-QLQ-BR23­).Results: Fifty females with mean age of 53.22±11.2 years were included. The median duration of lymphedema was 12 months. There were 22 patients in stage1, 26 in stage2 and 2 patients in stage3. The mean baseline limb and excess volumes were significantly decreased at the end of therapies (3262±753cm³ vs 2943±646.6cm³ and 31.36±16.5% vs 19.12±10.4%, p=0.000,respectively). The DASH and EORTC-QLQ-C30 and BR23 scores were also decreased significantly (p<0.05). The improvements in volumes were related negatively with the duration of lymphedema,and the stage of lymphedema. Conclusion: In conclusion phase 1CDT in a combined manner performed daily for 3 weeks, greatly reduces the volumes as well as improves the disability and QoL, especially when performed earlier.

Sign in / Sign up

Export Citation Format

Share Document